Shelton Capital Management’s CONMED CNMD Stock Holding History

Shelton Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,675	Closed	-$228K	–	702
2023 Q2	$228K	Buy	+1,675	New	+$204K	0.01%	638
2022 Q2	–	Sell	-1,871	Closed	-$278K	–	738
2022 Q1	$278K	Hold	1,871	–	–	0.01%	600
2021 Q4	$265K	Hold	1,871	–	–	0.01%	627
2021 Q3	$245K	Hold	1,871	–	–	0.01%	659
2021 Q2	$257K	Sell	1,871 -50	-3%	-$6.84K	0.01%	656
2021 Q1	$251K	Hold	1,921	–	–	0.01%	634
2020 Q4	$215K	Buy	+1,921	New	+$182K	0.01%	653
2020 Q1	–	Sell	-2,433	Closed	-$272K	–	689
2019 Q4	$272K	Hold	2,433	–	–	0.02%	579
2019 Q3	$234K	Sell	2,433 -186	-7%	-$17.5K	0.01%	669
2019 Q2	$224K	Buy	2,619 +2,401	+1,101%	+$197K	0.01%	718
2019 Q1	$2.62K	Buy	+218	New	+$15.8K	0.01%	757

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Shelton Capital Management's CNMD Position: Q3 2023 in Review

Shelton Capital Management sold out of CONMED (CNMD) in Q3 2023, closing a stake of 1,675 shares — an estimated $228K sold.

Shelton Capital Management first reported a position in CNMD in Q1 2019 and held it in 11 quarters. The position peaked at $278K in Q1 2022. 274 funds tracked by Wall St. Rank hold CNMD as of Q3 2023.

Shelton Capital Management reported no remaining CONMED position as of Q3 2023 after selling out during the quarter.
Shelton Capital Management sold 1,675 CONMED shares in Q3 2023, an estimated $228K.
Shelton Capital Management first reported a position in CONMED in Q1 2019 and held it in 11 quarters.
Shelton Capital Management's CONMED position peaked at $278K in Q1 2022.
274 funds tracked by Wall St. Rank held CONMED as of Q3 2023.

Based on Shelton Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.